Angelman Syndrome is an rare, neurogenetic condition that falls into the category of orphan diseases. Children’s Hospital Boston is pursuing clinical research in AS, taking part in the Angelman Syndrome Natural History study, and sponsoring a drug trial that has stirred up some hope for treating children with the disease.

Here’s the full story: